Growth Metrics

PROCEPT BioRobotics (PRCT) Return on Equity (2021 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Return on Equity for 5 consecutive years, with 0.26% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 3.0% to 0.26% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.26%, a 3.0% increase, with the full-year FY2025 number at 0.25%, up 2.0% from a year prior.
  • Return on Equity was 0.26% for Q4 2025 at PROCEPT BioRobotics, down from 0.22% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.27% in Q2 2021 to a low of 1.47% in Q3 2021.
  • A 5-year average of 0.37% and a median of 0.34% in 2022 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 114bps in 2022; the steepest drop was -55bps in 2022.
  • PROCEPT BioRobotics' Return on Equity stood at 0.22% in 2021, then tumbled by -85bps to 0.4% in 2022, then grew by 9bps to 0.36% in 2023, then increased by 22bps to 0.28% in 2024, then grew by 10bps to 0.26% in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Return on Equity are 0.26% (Q4 2025), 0.22% (Q3 2025), and 0.22% (Q2 2025).